Evidence map›Paper›PMID 28825944›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2017

Brief Report: Lopinavir Hair Concentrations Are the Strongest Predictor of Viremia in HIV-Infected Asian Children and Adolescents on Second-Line Antiretroviral Therapy.

Jillian Pintye, Peter Bacchetti, Sirinya Teeraananchai, Stephen Kerr, Wasana Prasitsuebsai, Thida Singtoroj, Karen Kuncze, Alexander Louie, Catherine A Koss, Chengshi Jin and 4 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05333679 (Urine Tenofovir Point-of-care Test to Identify Patients in Need of ART Adherence Support), which is not on this map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05333679 nacompletednot on this mapstarted 2022, after this paper: background citation

Urine Tenofovir Point-of-care Test to Identify Patients in Need of ART Adherence Support (UTRA Study)

TypeinterventionalSponsorUniversity of California, San FranciscoRan2022 to 2025Enrolled200ConditionsRisk ReductionArmsUTRA, UTRA feedback
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Measuring Adherence to Antiretroviral Therapy via Hair Concentrations in India.Journal of acquired immune deficiency syndromes (1999) · 2019
    Article
  16. Antiretroviral Concentrations in Hair Strongly Predict Virologic Response in a Large Human Immunodeficiency Virus Treatment-naive Clinical Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Jillian Pintye*Department of Global Health, University of Washington, Seattle, WA; †Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA; ‡HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand; §The Kirby Institute, University of New South Wales, Sydney, Australia; ‖GlaxoSmithKline (Thailand) Ltd., Bangkok, Thailand; ¶TREAT Asia/amfAR-The Foundation for AIDS Research, Bangkok, Thailand; and #Department of Medicine, University of California, San Francisco, San Francisco, CA.
Peter Bacchetti
Sirinya Teeraananchai
Stephen Kerr
Wasana Prasitsuebsai
Thida Singtoroj
Karen Kuncze
Alexander Louie
Catherine A Koss
Chengshi Jin
Nhi Phung
Howard Horng
Annette H Sohn
Monica Gandhi
University of California, San Francisco · USHIV Netherlands Australia Thailand Research Collaboration · THUniversity of Washington · USUNSW Sydney · AU

Funding

Clinical and Translational Science InstituteUL1TR001872 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COLLARD, HAROLD R, JACOBY, VANESSA · 2016 to 2025
$112.1M
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PETER W HUNT · 1988 to 2026
$93.6M
The Asia-Pacific HIV Research CollaborationU01AI069907 · NIAID · FOUNDATION FOR AIDS RESEARCH · PI ANNETTE H SOHN · 2006 to 2026
$44.8M
VENEREAL DISEASET32AI007140 · NIAID · UNIVERSITY OF WASHINGTON · PI Julia Cook Dombrowski · 1985 to 2026
$19.4M
UCSF/Kaiser-DOR Program for Developing Independent Women's Health ResearchersK12HD052163 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ADLER, NANCY E, BRINDIS, CLAIRE D. · 2005 to 2023
$9.3M
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention TrialsR01AI098472 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GANDHI, MONICA · 2012 to 2021
$5.6M
“Hair Lengthening”: Using Hair Levels to Interpret Long-Acting PrEP Studies.R37AI098472 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Monica Gandhi · 2023 to 2026
$3.2M
Statistical Methods for Complex HIV Cohort StudiesR01AI055085 · NIAID · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI BACCHETTI, PETER · 2002 to 2004
$1.4M
Adherence to Pre-Exposure Prophylaxis for HIV Prevention in PregnancyF32NR017125 · NINR · UNIVERSITY OF WASHINGTON · PI PINTYE, JILLIAN · 2017 to 2017
$61k
NCATS NIH HHS UL1 TR001872NIAID NIH HHS L30 AI113738NIAID NIH HHS P30 AI027763NIAID NIH HHS R01 AI055085NIAID NIH HHS R01 AI098472NIAID NIH HHS R37 AI098472NIAID NIH HHS T32 AI007140NIAID NIH HHS U01 AI069907NICHD NIH HHS K12 HD052163NINR NIH HHS F32 NR017125
6 · The paper itself

Abstract

backgroundChildren/adolescents display suboptimal antiretroviral therapy (ART) adherence and outcomes versus adults. Hair ART concentrations are objective adherence measures that predict viremia in adults but longitudinal data on hair levels in pediatric populations is limited. We assessed the predictive utility of hair lopinavir (LPV) levels on viremia among youth on second-line ART.

methodsWe examined predictors of viremia (HIV-1 RNA >400 and >1000 copies/mL) at least 24 weeks after switch to LPV-based second-line ART in a cohort of HIV-infected Asian children followed between 2011 and 2014. Small hair samples, HIV-1 RNA, and self-reported adherence were collected biannually. Hair concentrations of LPV were measured through liquid chromatography/tandem mass spectrometry using validated methods. Time-to-first viremia was examined using discrete-time Cox models.

resultsOverall, 244 children met the inclusion criteria for the present analysis. Approximately half (55%) were boys and the median age 10 years [interquartile range (IQR) 7-13]; 40% were older than 11 years. At switch to second-line ART, median CD4 count was 300 (IQR 146-547) cells/mm and median HIV-RNA level was 5.0 (IQR 4.3-5.6) log10/mL. Median time of study follow-up was 48 weeks and a median of 3 (range 1-5) hair samples were collected from each participant. Adjusting for age, sex, country, self-reported adherence, CD4, and HIV-RNA, higher LPV hair concentrations were the strongest predictor of lower odds of viremia (HIV-RNA >400 copies/mL adjusted odds ratio = 0.41 per doubling in hair concentration, 95% confidence interval: 0.29 to 0.58, P < 0.001; HIV-RNA >1000 copies/mL, adjusted odds ratio = 0.54, 95% confidence interval: 0.45 to 0.65, P < 0.001).

conclusionsHair concentrations predict viremia among children with HIV on second-line ART and could guide clinical decisions for this population.

Indexed as

Asian PeopleViremiaAdolescentAnti-HIV AgentsCD4 Lymphocyte CountChildDrug MonitoringFemaleHairHIV InfectionsHumansIndonesiaLongitudinal StudiesLopinavirMaleMedication AdherenceAnti-HIV AgentsLopinavir

Identifiers

PMID28825944
PMCPMC5659884
OpenAlexW2747640285

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.